Amoxicillin for Postexposure Inhalational Anthrax in Pediatrics: Rationale For Dosing Recommendations


    loading  Checking for direct PDF access through Ovid

Abstract

We reviewed information about the safety and plasma pharmacokinetic data for amoxicillin, specifically related to its potential use for postexposure inhalational anthrax. Amoxicillin (45 mg/kg/d) given orally in 3 divided doses to pediatric patients <40 kg should yield an adequate time above the MIC for susceptible Bacillus anthracis (≤0.5 μg/mL) over most of the dosing interval (75–100%). Doses <45 mg/kg/d and dosing intervals longer than 8 hours should not be used for postexposure inhalational anthrax.

    loading  Loading Related Articles